A short duration of risedronate administration may be useful in inhibiting bone resorption in periodontitis, whereas excessive dosages of the drug administered in longer durations can lead to impairment of bone formation and angiogenesis.

Rutin may be a potential adjuvant drug to reduce the hepatic side effects observed during Mtx therapy for various clinical conditions.

These results propose that dHPT may impair the health status of periodontium and may worsen the pathobiology of periodontal diseases.

No abstract

Our study revealed that intramuscular administration of parecoxib significantly attenuates vasospasm following experimental SAH.